Medical Automation Market Report 2026

The medical automation market size has grown rapidly in recent years. It will grow from $61.26 billion in 2025 to $67.91 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to shortage of healthcare workforce, rising patient volume in hospitals, need for operational efficiency, increasing medical errors in manual processes, early adoption of hospital information systems.

The medical automation market size is expected to see strong growth in the next few years. It will grow to $96.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growth in healthcare digitization, increasing demand for cost-efficient care delivery, expansion of robotic-assisted procedures, rising adoption of connected medical devices, increasing investments in smart hospitals. Major trends in the forecast period include increasing automation of clinical and administrative workflows, rising adoption of robotics in surgery and diagnostics, growing integration of software-driven automation platforms, expansion of automation in laboratories and pharmacies, rising demand for error reduction and patient safety solutions.

The rising prevalence of chronic diseases is anticipated to drive the expansion of the medical automation market in the coming years. Chronic diseases are long-term medical conditions that persist over time and generally worsen if not managed properly. Factors contributing to the rise in chronic diseases include sedentary lifestyles, poor dietary habits, and an aging population. Medical automation enables precise monitoring and timely interventions for chronic conditions, enhancing patient care and outcomes. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based federal public health agency, reported that approximately 129 million people in the United States suffer from at least one major chronic disease, including heart disease, cancer, diabetes, obesity, and hypertension. Consequently, the growing prevalence of chronic diseases is fueling the growth of the medical automation market.

Major companies operating in the medical automation market are concentrating on developing innovative solutions, such as clinician-controlled mobile apps, to boost revenue growth. A clinician-controlled mobile app is a software application created by healthcare professionals, including physicians, nurses, therapists, and other clinicians, to support various aspects of patient care, communication, and management. For example, in April 2024, Augmedix Inc., a US-based data services and medical documentation company, introduced Augmedix Go. This clinician-controlled mobile app utilizes ambient AI technology and structured data to generate a fully automated draft medical note following patient visits to healthcare settings such as emergency departments. This automation streamlines the medical documentation process, enabling clinicians to devote more time to patient care by minimizing time spent on administrative tasks like note-taking.

In September 2024, Hitachi Ltd., a Japan-based industrial technology company, acquired MA micro automation GmbH for an undisclosed amount. With this acquisition, Hitachi aims to strengthen its global robotic systems integration capabilities and broaden JR Automation’s footprint in medical and high-precision automation markets. MA micro automation GmbH is a Germany-based automation provider delivering production and testing systems for medical devices such as contact lenses, diagnostic consumables, and auto-injectors.

Major companies operating in the medical automation market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Becton, Dickinson and Company, Royal Philips, Stryker Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings Inc., Agilent Technologies Inc., Terumo Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., ResMed Inc., Bio Rad Laboratories Inc., QIAGEN N.V., Carl Zeiss Meditec AG, Masimo Corporation, Elekta AB, Tecan Group Ltd., Accuray Inc.

North America was the largest region in the medical automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical automation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs impact the medical automation market by increasing costs for imported medical robots, automation equipment, sensors, and software-enabled hardware components. Hospitals and diagnostic centers in regions reliant on imported capital equipment, particularly in asia-pacific and europe, may experience higher procurement costs and delayed automation projects. These tariffs can slow adoption in price-sensitive healthcare systems. However, they also encourage local manufacturing, system integration, and regional innovation in medical automation solutions.

The medical automation market research report is one of a series of new reports that provides medical automation market statistics, including medical automation industry global market size, regional shares, competitors with a medical automation market share, detailed medical automation market segments, market trends and opportunities, and any further data you may need to thrive in the medical automation industry. This medical automation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical automation is the application of technology and automated processes to enhance efficiency, accuracy, and safety across various areas of healthcare delivery, including diagnosis, treatment, monitoring, and administrative functions. It involves a range of automation solutions aimed at streamlining workflows, increasing efficiency, minimizing errors, and improving patient outcomes in healthcare settings such as hospitals, clinics, and laboratories.

The primary components of medical automation include equipment, capital equipment, consumables, software, and services. Equipment encompasses a wide range of devices, instruments, machines, and tools used in healthcare for diagnosing, treating, monitoring, and rehabilitating patients. These devices are interconnected through wired and wireless technologies. Automation is applied across numerous areas, including diagnostics and monitoring, therapeutics, laboratory and pharmacy automation, medical logistics and training, large-joint replacement, spinal fusion, and more, serving various end users such as hospitals, diagnostic centers, pharmacies, research laboratories and institutes, homecare providers, specialty clinics, ambulatory surgical centers (ASCs), and others.

The medical automation market consists of revenues earned by entities providing services such as electronic health records (EHR) management, patient engagement and education, medical imaging automation, and patient monitoring systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical automation market also includes sales of automated vaccine storage and handling systems, sensors, automated sterilization systems, automated external defibrillators (AEDs), and automated laboratory instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.